Skip to main content
OpenTrials

Clinical trial condition

Systemic Sclerosis (SSc)

Explore clinical trials studying Systemic Sclerosis (SSc). Study availability and eligibility vary by location and protocol.

77 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Systemic Sclerosis (SSc) trial results

Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

NCT06655155

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Arizona Arthritis and Rheumatology Associates Phoenix, Arizona, United States
  • UCLA Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Illinois Health Outpatient Care Center Chicago, Illinois, United States
View all 76 locations
View Trial Details
Recruiting

Controlling Hyperactive Immunity With Long-lived Lymphocytes

NCT07473154

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +13 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Guy's & St Thomas NHS Foundation Trust London, United Kingdom
  • Royal Free London NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

US Zamto-cel Autoimmune Diseases

NCT06708845

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +17 more
Locations
  • Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

NCT06308978

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Autoimmune Diseases, +28 more
Locations
  • Wallace Rheumatic Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • University of California Irvine Irvine, California, United States
  • Children's Hospital Los Angeles Division Of Rheumatology Los Angeles, California, United States
View all 21 locations
View Trial Details
Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT06991114

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Artiva Investigational Site Tuscaloosa Tuscaloosa, Alabama, United States
  • Artiva Investigational Site Phoenix Phoenix, Arizona, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site Chula Vista Chula Vista, California, United States
View all 52 locations
View Trial Details

Related conditions